“sangamo-therapeutics” Archives

in
Entry Author Date Location
FDA Rejects BioMarin Hemophilia Gene Therapy, Asks for More Data 08/19/20 National
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Novartis Pays $75M to Get Hands on Sangamo’s Zinc Fingers for Drug R&D 07/30/20 San Francisco
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy 06/25/20 Philadelphia
Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact 06/01/20 New York
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic 02/18/20 Boston
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans 01/13/20 Boston
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule 11/25/19 San Francisco
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
Genomics Experts Preview Xconomy’s Aug. 27 Bay Area Biotech Forum 08/14/19 National
Turning Genomics Into Better Health on Aug. 27: Early Bird Rate Ends Soon 08/07/19 San Francisco
Xconomy’s August San Francisco Event to Focus on Genomics and Health 07/29/19 San Francisco
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
As Sangamo Touts Data, BioMarin Preps Hemophilia Gene Therapy For FDA 07/08/19 San Francisco
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit 02/07/19 San Francisco
Sangamo 1st to Show Human Gene-Editing Results. Investors Say ‘Meh.’ 09/05/18 San Francisco
RootPath Raises $7M to Bring Cancer Cell Therapy to Solid Tumors 08/30/18 Boston
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More 08/10/18 National
Bluebird’s Upgraded Gene Therapy Shows Promise For Sickle Cell Patients 06/15/18 Boston
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More 02/23/18 National
Continuing Cell Therapy Push, Gilead Aligns with Sangamo for CAR-T Boost 02/22/18 San Francisco
15 For ’18: Key Clinical Data to Watch For Next Year (Part 2) 12/06/17 National
Page 1 of 1